menu search

Dallas fed service sector outlook -18.2 vs -8.6 prior

This is the lowest since December 2022 and just above the post-covid lows This article was written by A...

October 31, 2023, 2:33 pm

Pfizer's (pfe) q3 loss narrows, sales miss on covid slump

Pfizer (PFE) reports mixed third-quarter 2023 results. It re-affirms its 2023 sales and earnings guidance provided earlier this month....

October 31, 2023, 12:46 pm

3 airline stocks that could make a comeback in 2024

The airline industry continues to heal from the Covid-19 pandemic. With aircraft sitting empty and idle on tarmacs around the world, the global aviati...

October 31, 2023, 12:36 pm

Us employment cost index at for q3 1.1% versus 1.0% expectation

Prior quarter 1.0%Employment cost index 1.1% versus 1.0% expectedWages 1.2% versus 1.0% last quarterEmployment benefits 0.9% versus 0.9% last quarterL...

October 31, 2023, 12:30 pm

Innovation could propel biotechnology bounce

Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vacc...

October 31, 2023, 11:28 am

Pfizer earnings weighed down again by dwindling covid sales

Unused stockpiles of COVID-19 treatment Paxlovid and muted demand for the same illness' vaccine weighed down on Pfizer's (PFE) third quarter earnings....

October 31, 2023, 10:15 am

Pfizer q3 earnings beat does little for the battered share price

A smaller-than-expected third-quarter loss from Pfizer Inc (NYSE:PFE) was not enough to move the stock pre-market as it revealed the scars from a tail...

October 31, 2023, 8:13 am

Pfizer swings to quarterly loss due to paxlovid, covid vaccine write-offs

CNBC's Joe Kernen reports on the company's quarterly earnings results....

October 31, 2023, 7:51 am

Pfizer swings to quarterly loss due to paxlovid, covid vaccine write-offs

The results come two weeks after Pfizer slashed its full-year adjusted earnings and revenue guidance and launched a sweeping $3.5 billion cost-cutting...

October 31, 2023, 7:03 am

Pfizer swings to quarterly loss due to paxlovid write-off

Pfizer on Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its ...

October 31, 2023, 6:49 am

Revisiting the classic 60/40 portfolio as challenges loom

In mid-2020, the 60/40 worked as well as it was supposed to. Investors who held on through the early covid ...

October 31, 2023, 6:16 am

Urbana establishes new fund to support small businesses

On Friday, the Champaign County Economic Development Corporation announced the establishment of the COVID-19 Recovery: Urbana Small Business Microloan...

October 31, 2023, 3:29 am

Ieo: the long-term case is real

The iShares U.S. Oil & Gas Exploration & Production ETF (IEO) is a compelling investment option for those looking to gain exposure to the oil and gas ...

October 30, 2023, 11:56 am

Pfizer's (pfe) key drugs to drive q3 earnings amid covid decline?

Pfizer (PFE) expects better non-covid operational revenue growth sequentially in the third quarter, dri...

October 30, 2023, 10:33 am

Pfizer rsv vaccine lags gsk's as head-to-head competition underway

Pfizer , which dominated covid vaccine sales, now finds itself looking up at GSK , whose rival new resp...

October 30, 2023, 6:35 am

3 beaten-down dividend stocks you could regret not buying on the dip

Ally Financial is a digital bank that offers a dividend yield above 5% at recent prices. Thermo Fisher Scientific's COVID-19 testing revenue has evapo...

October 30, 2023, 5:57 am

Willis lease finance corporation: significantly undervalued assets and strong industry tailwinds

Willis Lease Finance Corporation is a good business that is likely to continue growing. The company's book value is significantly understated due to t...

October 30, 2023, 2:30 am

Charter: fiber and fwa won't kill cable

Like many Covid-profiteers Charter has been a profitable short for the past two years. In addition, at first sight, operational trends are looking bad...

October 30, 2023, 1:10 am

Wave goodbye: 3 stocks to ditch as revenge travel dies down

Although the collective pent-up demand for social experiences amid the worst of the Covid-19 crisis led to the revenge travel phenomenon, this catalys...

October 29, 2023, 4:18 pm

3 no-brainer stocks to buy for under $100 right now

AstraZeneca's slump presents a great buying opportunity. BioNTech's future prospects go well beyond COVID-19....

October 28, 2023, 6:50 am


Search within

Pages Search Results: